Melanonychia due to hydroxyurea

Descripción del Articulo

We present the case of an 85-year-old woman who was diagnosed with essential thrombocytosis; and, who, after six months receiving therapy with hydroxyurea, she noticed her fingernails turned dark. The exact mechanism for this occurrence is still unknown. We should pay attention to this unusual compl...

Descripción completa

Detalles Bibliográficos
Autor: Pamo-Reyna, Oscar G.
Formato: artículo
Fecha de Publicación:2024
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/2861
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2861
Nivel de acceso:acceso abierto
Materia:Hydroxyurea
Nail diseases
Drug-Related Side Effects and Adverse Reactions
id REVCMP_756e370a652d711bdfe53e35fa74cd20
oai_identifier_str oai:ojs.pkp.sfu.ca:article/2861
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Melanonychia due to hydroxyureaMelanoniquia debida a hidroxiureaPamo-Reyna, Oscar G.HydroxyureaNail diseasesDrug-Related Side Effects and Adverse Reactions We present the case of an 85-year-old woman who was diagnosed with essential thrombocytosis; and, who, after six months receiving therapy with hydroxyurea, she noticed her fingernails turned dark. The exact mechanism for this occurrence is still unknown. We should pay attention to this unusual complication that may lead to interrupt or modify therapy. Se presenta el caso de una mujer de 85 años a quien se diagnosticó con trombocitosis esencial y que, tras seis meses de tratamiento con hidroxiurea, notó el ennegrecimiento de sus uñas. Aún se desconoce el mecanismo exacto por el cual ocurre este fenómeno. Se debe prestar atención a esta inusual complicación ungueal que puede llevar a interrumpir o modificar el tratamiento.Colegio Médico del Perú2024-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmltext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/286110.35663/amp.2024.412.2861ACTA MEDICA PERUANA; Vol 41 No 2 (2024): April - June; 144-146ACTA MEDICA PERUANA; Vol. 41 Núm. 2 (2024): Abril - Junio; 144-1461728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2861/1643https://amp.cmp.org.pe/index.php/AMP/article/view/2861/1669https://amp.cmp.org.pe/index.php/AMP/article/view/2861/1670Copyright (c) 2024 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/28612024-11-18T07:47:26Z
dc.title.none.fl_str_mv Melanonychia due to hydroxyurea
Melanoniquia debida a hidroxiurea
title Melanonychia due to hydroxyurea
spellingShingle Melanonychia due to hydroxyurea
Pamo-Reyna, Oscar G.
Hydroxyurea
Nail diseases
Drug-Related Side Effects and Adverse Reactions
title_short Melanonychia due to hydroxyurea
title_full Melanonychia due to hydroxyurea
title_fullStr Melanonychia due to hydroxyurea
title_full_unstemmed Melanonychia due to hydroxyurea
title_sort Melanonychia due to hydroxyurea
dc.creator.none.fl_str_mv Pamo-Reyna, Oscar G.
author Pamo-Reyna, Oscar G.
author_facet Pamo-Reyna, Oscar G.
author_role author
dc.subject.none.fl_str_mv Hydroxyurea
Nail diseases
Drug-Related Side Effects and Adverse Reactions
topic Hydroxyurea
Nail diseases
Drug-Related Side Effects and Adverse Reactions
description We present the case of an 85-year-old woman who was diagnosed with essential thrombocytosis; and, who, after six months receiving therapy with hydroxyurea, she noticed her fingernails turned dark. The exact mechanism for this occurrence is still unknown. We should pay attention to this unusual complication that may lead to interrupt or modify therapy.
publishDate 2024
dc.date.none.fl_str_mv 2024-06-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2861
10.35663/amp.2024.412.2861
url https://amp.cmp.org.pe/index.php/AMP/article/view/2861
identifier_str_mv 10.35663/amp.2024.412.2861
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2861/1643
https://amp.cmp.org.pe/index.php/AMP/article/view/2861/1669
https://amp.cmp.org.pe/index.php/AMP/article/view/2861/1670
dc.rights.none.fl_str_mv Copyright (c) 2024 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2024 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
text/xml
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 41 No 2 (2024): April - June; 144-146
ACTA MEDICA PERUANA; Vol. 41 Núm. 2 (2024): Abril - Junio; 144-146
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075113345318912
score 13.949927
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).